Skip to main content
SpringerLink
Log in
Book cover

Hepatic Encephalopathy in Chronic Liver Failure pp 25–40Cite as

γ-Aminobutyric Acid Receptors in Experimental Hepatic Encephalopathy

  • Chapter

Abstract

Studies on the pathogenesis of hepatic encephalopathy (HE) following fulminant hepatic failure (FHF) have focused on biochemical changes occurring in blood, in cerebrospinal fluid or in brain with the aim of recognizing the primary factors leading to the central nervous system (CNS) dysfunction of coma. Because of the numerous metabolic abnormalities found in this pathology a congeries of theories has been generated, but none of these is so fully proved as to be accepted.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D. Keppler, R. Lesch, W. Reutter, and K. Decker, Experimental hepatitis induced by D-galactosamine, Exp. Mol. Path. 9: 279 (1968).

    Article  CAS  Google Scholar 

  2. B. L. Blitzer, J. G. Waggoner, E. A. Jones, H. R. Gralnick, D. Towne, V. Weise, I. J. Kopin, I. Walters, P. F. Teichenne, D. Goodman, and P. D. Berk, A model of fulminant hepatic failure in rabbit, Gastroenterology 74: 664 (1978).

    PubMed  CAS  Google Scholar 

  3. E. Chirito, C. Lister, and T. M. S. Chang, Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment, Artif. Organs 3: 42 (1979).

    CAS  Google Scholar 

  4. M. L. Zeneroli, A. Penne, G. Parrinello, C. Cremonini, and E. Ventura, Comparative evaluation of Visual Evoked potentials in experimental hepatic encephalopathy and in pharmacologically induced coma-like states in rat, Life Sci., 28: 1507 (1981).

    Article  PubMed  CAS  Google Scholar 

  5. M. Baraldi, M. L. Zeneroli, P. Ricci, E. Caselgrandi, and E. Ventura, Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy, Life Sci. (in press)

    Google Scholar 

  6. J. E. Fischer and R. J. Baldasserini, Pathogenesis and therapy of hepatic coma in: “Progress in Liver Diseases”, H. Popper and F. Schaffer eds., Grune and Stratton, New York (1975).

    Google Scholar 

  7. M. L. Zeneroli, E. Ventura, M. Baraldi, A. Penne, E. Messori,and L. Zieve, Ammonia, mercaptans and short chain fatty acids as pathogenetic agents of hepatic encephalopathy: evaluation by visual evoked potentials, Hepatology 2: 532 (1982).

    CAS  Google Scholar 

  8. H. Conn and M. M. Lieberthal, The syndrome of portal-systemic encephalopathy, in: “The Hepatic Coma Syndromes and Lactulose”. H. Conn and M. M. Lieberthal eds., Williams and Wilkins, Baltimore (1979).

    Google Scholar 

  9. W. A. Coob and G. D. Dawson, The latency and form in many of the occipital potentials evoked by bright flashes, J. Physiol. 152: 108 (1960).

    Google Scholar 

  10. D. F. Schafer, L. E. Brody, and E. A. Jones, Visual evoked potentials: an objective measurement of hepatic encephalopathy in the rabbit, Gastroenterology 77, A38 (1979).

    Google Scholar 

  11. I. Bodis-Wollner, Evoked potentials, Ann. N.Y. Ac. Sci. 388: 1 (1981).

    Google Scholar 

  12. M. L. Zeneroli, C. Cremonini, C. Gollini, G. Pinelli, A. Penne, E. Messori, and M. Baraldi, Effects of hyperammoniemia and of hypoglycemia on visual evoked potentials in rat: comparison with hepatic encephalopathy, Riv. Farmacol. Terap. 13: 35 (1982).

    CAS  Google Scholar 

  13. D. F. Schafer and E. A. Jones, Hepatic encephalopathy and the y-aminobutyric acid neurotransmitter system, Lancet 1: 18 (1982).

    Article  PubMed  CAS  Google Scholar 

  14. D. F. Schafer and E. A. Jones, Potential neuronal mechanisms in the pathogenesis of hepatic encephalopathy in: “Progress in Liver Diseases”, H. Popper and F. J. Schaffner eds.,Grune and Stratton, New York (1982).

    Google Scholar 

  15. R. A. Nicoll, J. C. Eccles, T. Oshima, and F. Rusia, Prolongation of hippocampal postsynaptic potentials by barbiturates, Nature 258: 625 (1975).

    Article  PubMed  CAS  Google Scholar 

  16. R. H. Evans, Potentiation of the effects of GABA by pentobarbitone, Brain Res. 171: 113 (1979).

    Article  PubMed  CAS  Google Scholar 

  17. A. Guidotti, M. Baraldi, and E. Costa, 1–4 benzodiazepines and gamma-aminobutyric acid: pharmacological and biochemical correlates, Pharmacology 19: 267 (1979).

    Article  PubMed  CAS  Google Scholar 

  18. F. Rossi-Fanelli, H. Freund, R. Krause, A. R. Smith, J. H. James, S. Castorina-Ziparo, and J. E. Fischer; Induction of coma in normal dogs by the infusion of aromatic amino acids and its prevention by the addition of branched-chain amino acids, Gastroenterology 83: 664 (1982).

    PubMed  CAS  Google Scholar 

  19. A. P. Bernardi, W. Chance, and J. E. Fischer, Depression of neurological function by intraventricular octopamine and tryptophan, Gastroenterology 82: 1222 (1982).

    Google Scholar 

  20. L. Zieve, The mechanism of hepatic coma, Hepatology 1: 360 (1981).

    Article  PubMed  CAS  Google Scholar 

  21. S. Schenker, K. Breen, and A. M. Hoyumpa, Hepatic encephalopathy: current status, Gastroenterology 66: 121 (1974).

    PubMed  CAS  Google Scholar 

  22. H. Conn and M. M. Lieberthal, Pathogenesis of portal-systemic encephalopathy, in: “The Hepatic Coma Syndromes and Lactulose”, H. Conn and M. M. Lieberthal eds., Williams and Wilkins, Baltimore (1979).

    Google Scholar 

  23. E. Polli, Il coma epatico, in “Quaderni di Neurofarmacologia”, V. Andreoli, A. De Maio, and M. P. Nielsen eds., Ravizza, Milano (1972).

    Google Scholar 

  24. A. M. Mans, S. J. Sanders, R. E. Kirsch, and J. F. Biebuyck, Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat, J. Neurochem. 32: 285 (1978).

    Article  Google Scholar 

  25. S. S. Oja, P. Kontro, and P. Landesmaki in: “Amino Acids as Inhibitory Neurotransmitters” S.S. Oja, P. Kontro, and P. Landesmaki eds., Gustav Verlag, Stuttgart, New York (1977).

    Google Scholar 

  26. M. L. Zeneroli, E. Iuliano, G. Racagni, and M. Baraldi, Metabolism and brain uptake of y-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats, J. Neurochem. 38: 1219 (1982).

    Article  PubMed  CAS  Google Scholar 

  27. A. S. Livingstone, M. Potwin, C. A. Goresky, M.H. Finlayson, and E. J. Hinchey, Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat, Gastroenterology 73: 697 (1977).

    PubMed  CAS  Google Scholar 

  28. M. Baraldiand M.L.Zeneroli, 3H-GABA binding in galactosamineHC1 induced hepatic encephalopathy in rat: a denervation supersensitivity phenomenon, Soc. Neuroscience 7: 511A (1981).

    Google Scholar 

  29. M. Baraldi and M. L. Zeneroli, Experimental hepatic encephalopathy: changes in y-aminobutyric acid, Science 216: 427 (1982).

    Article  PubMed  CAS  Google Scholar 

  30. M. Baraldi and M. L. Zeneroli, Experimental hepatic encephalopathy: a model to study a distinct high affinity GABA receptors, in “Dynamics of Neurotransmitter Function” I. Hanin ed., Raven Press, New York, in press.

    Google Scholar 

  31. J. I. Waddington and A. J. Cross, Denervation supersensitivity in the striato-nigral GABA pathway,Nature 276: 618 (1978).

    Article  PubMed  CAS  Google Scholar 

  32. A. Guidotti, K. Gale, A. Suria, and G. Toffano, Biochemical evidence for two classes of GABA receptors in rat brain, Brain Res. 172: 556 (1979).

    Article  Google Scholar 

  33. K. Kuriyama, E. Kuriahara, Y. Iti, and Y. Yoneda, Increase in striatal 3H-Muscimol binding following intrastriatal injection of kainic acid: a denervation supersensitivity phenomenon, J. Neurochem. 35: 343 (1980).

    Article  PubMed  CAS  Google Scholar 

  34. N. H. Dierner, Glial and neuronal changes in experimental hepatic encephalopathy. A quantitative morphological investigation, Acta Neurol. Scand. 71: 58 (1978).

    Google Scholar 

  35. M. Massotti, A. Guidotti, and E. Costa, Characterization of benzodiazepine and y-aminobutyric recognition sites and their endogenous modulators, J. Neurochem. 1: 409 (1981).

    CAS  Google Scholar 

  36. A. Guidotti, M. Baraldi, A. Leon, and E. Costa, Benzodiazepines: a tool to explore the biochemical and neurophysiological basis of anxiety, Fed. Proc. 39: 3039 (1980).

    CAS  Google Scholar 

  37. M. Brower, J. W. Ferkany, and S. J. Enna, Biochemical identification of pharmacologically and functionally distinct GABA receptors in rat brain, J. Neuroscience 1: 514 (1981).

    Google Scholar 

  38. M. Baraldi, Evidence that benzodiazepine receptors are coupled with high affinity GABA binding sites in rat brain, Neuroscience Letters 10 (Suppl.): S-58 (1982).

    Google Scholar 

  39. M. Baraldi, E. Caselgrandi, P. Borella, C. Cremonini, and M. L. Zeneroli, Zinc content in brain tissue and GABA receptor function in experimental hepatic encephalopathy, in: “Application of Behavioral Pharmacology in Toxicology” V. Cuomo and G. Racagni eds., Raven Press, New York, in press.

    Google Scholar 

  40. J. Y. Wu and E. Robert, Properties of brain L-glutamate decarboxylase: inhibition studies, J. Neurochem. 23: 759 (1974).

    Article  PubMed  CAS  Google Scholar 

  41. Th. De Boer, J. Bruinels, and I. L. Bonta, Differential effects of GABA analogues and zinc on glutamate decarboxylase, 4aminobutyric-2-oxoglutaric acid transaminase and succinate semildehyde dehydrogenase in rat brain tissue, J. Neurochem. 33: 597 (1979).

    Article  PubMed  Google Scholar 

  42. M. Chvapil, New aspects in the biological role of zinc: a stabilized of macromolecules and biological membranes, Life Sci. 13: 1041 (1973).

    Article  PubMed  CAS  Google Scholar 

  43. M. Baraldi, E. Caselgrandi, P. Borella, and M. L. Zeneroli, Decrease of brain zinc in experimental hepatic encephalopathy, Brain Res., in press.

    Google Scholar 

  44. L. Zieve, W. M. Doizaki, and F. J. Zieve, Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma, J. Lab. Clin. Med. 83: 16 (1974).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituti di Clinica Medica III e di Farmacologia, Università di Modena, 41100, Modena, Italy

    M. L. Zeneroli, M. Baraldi & E. Ventura

Authors
  1. M. L. Zeneroli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Baraldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Ventura
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Rome, Rome, Italy

    Livio Capocaccia  & Filippo Rossi-Fanelli  & 

  2. Department of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA

    Joseph E. Fischer

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Zeneroli, M.L., Baraldi, M., Ventura, E. (1984). γ-Aminobutyric Acid Receptors in Experimental Hepatic Encephalopathy. In: Capocaccia, L., Fischer, J.E., Rossi-Fanelli, F. (eds) Hepatic Encephalopathy in Chronic Liver Failure. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4787-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4787-3_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4789-7

  • Online ISBN: 978-1-4684-4787-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation